Pituitary Neoplasms Clinical Trial
Official title:
Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions
The purpose of this four-arm randomized controlled study is to determine whether eliminating glucocorticoids (GC) replacement in perioperative period in surgical patients with sellar lesion could result in similar or better outcomes comparing to traditional replacement therapy, regarding postoperative recovery of pituitary function and other postoperative complications (infection, pain, quality of life, recurrence). Surgical patients of our center with MRI-confirmed diagnosis of sellar lesion will be enrolled, insulin tolerance test (ITT) will be performed for assessment of the pituitary function at enrollment. Patients with normal pituitary function will be randomized into non-GC replacement group (group A) and low-dose GC replacement group (group B), while patients with impaired pituitary function will be randomized into low-dose GC replacement group (group C) and high-dose GC replacement group (group D). The primary outcome is the hypothalamic-pituitary-adrenal (HPA) -axis function of the patients, evaluated by plasma cortisol and adrenocorticotropic hormone (ACTH) levels. The secondary outcomes include the hypothalamic-pituitary-thyroid (HPT) axis function (TSH, thyroid-stimulating hormone, free T3, free T4), postoperative water-electrolyte balance, infection, recurrence and health-related quality of life.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02549768 -
Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery
|
Phase 4 | |
Terminated |
NCT02629549 -
Intraoperative Imaging of Pituitary Adenomas by OTL
|
Phase 1 | |
Recruiting |
NCT02288962 -
Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas
|
Phase 3 | |
Terminated |
NCT02743442 -
Da Vinci Transoral Robotic-assisted Surgery of Pituitary Gland
|
N/A | |
Completed |
NCT02632084 -
Follow-up Evaluation of Photo-Dynamic Therapy for Pituitary Tumours
|
N/A | |
Not yet recruiting |
NCT06282224 -
Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery
|
N/A | |
Recruiting |
NCT05108064 -
Radiomic and Pathomic Study of Pituitary Adenoma Using Machine Learning
|
||
Active, not recruiting |
NCT03665064 -
Long Term Outcome Study in Patients With Pituitary Disorders
|
||
Recruiting |
NCT01775332 -
Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
|
N/A | |
Completed |
NCT05088252 -
Desflurane and Anesthesia Recovery Period in Endonasal Endoscopic Pituitary Adenoma Resection
|
N/A |